Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abediterol dose-ranging study in symptomatic asthma on inhaled corticosteroids
2016-004140-10Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of abediterol in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Change from baseline in morning trough FEV1 on Day 29. Started Jul 2017; status: completed.
02
Drugs
abediterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2016-004140-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004140-10.